Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 12, 2006, Pages 5437-5446

  Framme, Carsten ^a,b   Sachs, Helmut G ^b   Flucke, Barbara ^a   Theisen Kunde, Dirk ^a   Birngruber, Reginald ^a  

^a MEDICAL LASER CENTER LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PALLADIUM BACTERIOPHEOPHORBIDE; PHOTOSENSITIZING AGENT; BACTERIOCHLOROPHYLL; PALLADIUM-BACTERIOPHEOPHORBIDE;

ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID; ENDOTHELIUM CELL; LASER; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PRIORITY JOURNAL; RABBIT; ANIMAL; DRUG EFFECT; DRUG SCREENING; FLUORESCENCE ANGIOGRAPHY; PATHOLOGY; PHOTOCHEMOTHERAPY; SUBRETINAL NEOVASCULARIZATION; VASCULARIZATION;

ANIMALS; BACTERIOCHLOROPHYLLS; CHOROID; CHOROIDAL NEOVASCULARIZATION; DRUG EVALUATION, PRECLINICAL; FLUORESCEIN ANGIOGRAPHY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RABBITS;

EID: 34248138433     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0532     Document Type: Article

References (36)

1. Manyak MJ, Russo A, Smith PD, Glatstein E. Photodynamic therapy. J Clin Oncol. 1988;6:380-391.
2. Gomer C. Photodynamic therapy in the treatment of malignancies. Semin Hematol. 1989;26:27-31.
3. Bressler NM, Bressler SB, Gragoudas ES. Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol. 1987;105: 209-213.
4. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32:375-413.
5. O'Connell SR, Bressler NM. Age-related macular degeneration. In: Regillo CD, Brown GC, Flynn HW Jr, eds. Vitreoretinal Disease: the Essentials. New York: Thieme Medical Publishers; 1999:213-240.
6. Husain D, Gragoudas ES, Miller JW. Photodynamic therapy. In: Berger JW, Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St. Louis, MO: Mosby; 1999:297-307.
7. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol. 1999;117:1329-1345.
8. Husain D, Miller JW, Michaud N, Connolly E, Flotte TJ, Gragoudas ES. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthlamol. 1996;114:978-985.
9. Kliman GH, Puliafito CA, Grossman GA, Gregory WA. Retinal and choroidal vessel closure using phthalocyanine photodynamic therapy. Lasers Surg Med. 1994;15:11-18.
10. Peyman GA, Moshfeghi DM, Moshfeghi A, et al. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2). Ophthalmic Surg Lasers. 1997;28:409-417.
11. Kazi AA, Peyman GA, Unal M, et al. Threshold power levels for Npe6 photodynamic therapy. Ophthalmic Surg Lasers. 2000;31: 136-142.
12. Fiedor L, Gorman AA, Hamblett I, et al. A pulsed laser and pulse radiolysis study of amphiphilic chlorophyll derivatives with PDT activity toward malignant melanoma. Photochem Photobiol. 1993; 58:506-511.
13. Zilberstein J, Bromberg A, Frantz A, et al. Light dependent oxygen consumption in bacteriochlorophyll serine treated melanoma tumors: on line determination using a tissue inserted oxygen microsensor. Photochem Photobiol. 1997;65:1012-1019.
14. Rosenbach-Belkin V, Chen L, Fiedor L, Salomon Y, Scherz A. Chlorophyll and bacteriochlorophyll derivatives as photodynamic agents. In: Moser JG, ed. Photodynamic Tumor Therapy 2nd and 3rd Generation Photosensitizers. London, UK: Routledge 1998; 117-125.
15. Scherz A, Katz S, Vakrat Y, et al. Bacteriochlorophyll-serine based photochemotherapy: type III PDT? Photosynthesis - Mechanisms and Effects. Vol 5. Dordrecht: Kluwer Academic Publications; 1998:4207-4212.
16. Zilberstein J, Rosenbach-Belkin V, Neeman M, et al. Bacteriochlorophyll based PDT of solid tumors relies on vascular destruction. Proceedings of the 7th Biennial Congress. The International Photodynamic Association, Nantes, France. 1999.
17. Birngruber R, Gabel VP, Hillenkamp F. Experimental studies of laser thermal retinal injury. Health Phys. 1983;44:519-531.
18. Brinkmann R, Meyer W, Engelhardt R, Walling JC. Laser induced Shockwave lithotripsy by use of an 1 μs Alexandrite laser. Proc SPIE. 1990;1200:67-74.
19. Scherz A, Salomon Y, Fiedor L. Chlorophyll and bacteriochlorophyll derivatives, preparation, and pharmaceutical compositions comprising them as photosensitizers for photodynamic therapy. Chem Abstr. 1994;120:386.
20. Gabel VP, Birngruber R, Hillenkamp F. Visible and near infrared light absorption in pigment epithelium and choroid. In: Shimizu K, ed. International Congress Series No. 450, XXIII Concilium Ophthalmologicum, Kyoto. Princeton, NJ: Excerpta Medica; 1978: 658-662.
21. Birngruber R, Hillenkamp F, Gabel VP. Experimentelle und theoretische Untersuchungen zur thermischen Schädigung des Augenhintergrundes durch Laserstrahlung; Gesellschaft für Strahlen- und Umweltforschung m.b.H, München; GSF-Report, AO251 1978.
22. Sliney DH, Wolbarsht ML. Safety with Lasers and Other Optical Sources. New York: Plenum Press; 1980.
23. Finney DJ. Probit Analysis. 3rd ed. London: Cambridge University Press; 1971.
24. Rosenbach-Belkin V, Chen L, Fiedor L, et al. Serine conjugates of chlorophyll and bacteriochlorophyll: photocytotoxicity in vitro and tissue distribution in mice bearing melanoma tumors. Photo chem Photobiol. 1996;64:174 -181.
25. Ben-Hur E, Heldman E, et al. Release of clotting factors from photosensitized endothelial cells: a possible trigger for blood vessel occlusion by photodynamic therapy. FEBS Lett. 1988;236:105-108.
26. Husain D, Kramer M, Kenny AG, et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci. 1999;40:2322-2331.
27. Schmidt-Erfurth U, Hasan T, Gragoudas E, Michaud N, Flotte TJ, Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology. 1994;101:1953-1961.
28. Matsumoto M, Miki T, Obana A, et al. Choroidal damage in dyeenhanced photocoagulation. Lasers Light Ophthalmol. 1993;5: 157-165.
29. Schmidt-Erfurth U, Hasan T. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol. 2000;45:195-214.
30. Woodburn KW, Engelman CJ, Blumenkranz MS. Photodynamic therapy for choroidal neovascularization. Retina. 2002;22:391-405.
31. Young SW, Woodburn KW, Wright M, et al. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem Photobiol. 1996;63:892-897.
32. Mori K, Yoneya S, Ohta M, et al. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorine e6). Ophthalmology. 1999;106: 1384-1391.
33. Peyman GA, Kazi AA, Unal M, et al. Problems with and pitfalls of photodynamic therapy. Ophthalmology. 2000;107:29-35.
34. Obana A, Gohto Y, Kaneda K, et al. Selective occlusion of the choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10. Lasers Surg Med. 1999;24: 209-222.
35. Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T. PDT to monkey CNV with ATX-S10(Na): Inappropriateness of early laser irradiation for selective occlusion. Invest Ophthalmol Vis Sci. 2001;42:2639-2645.
36. Okunaka T, Eckhauser MC, Kato H. Correlation between photodynamic efficacy of different porphyrins and membrane partitioning behaviour. Lasers Surg Med. 1992;12:98-103.